Literature DB >> 35915675

Post-Fever Retinitis.

Pranaykumar Shinde1, Sachin Daigavane1, Avi Sharma1.   

Abstract

A 34-year-old male presented with a gradual, painless decrease in distant vision in the left more than the right in the past 15 days. He had a history of an episode of fever seven days prior to ocular symptoms and had been treated with oral Cefixime and antipyretics. On detailed fundus examination, both eyes showed creamy white superficial lesions with ill-defined margins, suggestive of retinitis, with a few hemorrhages along the inferior arcade associated with sheathing of vessels and telangiectatic vessels near the lesion. Fundus fluorescein angiography (FFA) of both eyes in the venous phase depicted blocked fluorescence at the site of retinitis lesions with hyperfluorescence at their borders. Optical coherence tomography (OCT) of both eyes showed inner retinal layer hyper-reflectivity with neurosensory detachment (NSD) with hyper-reflective deposits in it and dilated choroidal vessels. The diagnosis of both eyes' post-fever retinitis (PFR) was made, and he was investigated for complete blood count, peripheral smear, erythrocyte sedimentation rate, and HIV Tridot test, which were normal. He was treated with intravitreal triamcinolone acetonide (2 mg/0.05 ml) in both eyes.
Copyright © 2022, Shinde et al.

Entities:  

Keywords:  fundus fluorescein angiography (ffa); oct (optical coherence tomography); post fever; retinitis; triamcinolone acetonide

Year:  2022        PMID: 35915675      PMCID: PMC9337596          DOI: 10.7759/cureus.26429

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  2 in total

1.  Post-fever retinitis: a single center experience from south India.

Authors:  Srilatha Vishwanath; Kalpana Badami; K S Sriprakash; B L Sujatha; S D Shashidhar; Y D Shilpa
Journal:  Int Ophthalmol       Date:  2013-12-21       Impact factor: 2.031

2.  Commentary: Post fever retinitis and vasculitis: A morphological conundrum.

Authors:  Bhavik Panchal
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.